These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 19459854)

  • 1. Quantification of mouse pulmonary cancer models by microcomputed tomography imaging.
    Fushiki H; Kanoh-Azuma T; Katoh M; Kawabata K; Jiang J; Tsuchiya N; Satow A; Tamai Y; Hayakawa Y
    Cancer Sci; 2009 Aug; 100(8):1544-9. PubMed ID: 19459854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A quantitative volumetric micro-computed tomography method to analyze lung tumors in genetically engineered mouse models.
    Haines BB; Bettano KA; Chenard M; Sevilla RS; Ware C; Angagaw MH; Winkelmann CT; Tong C; Reilly JF; Sur C; Zhang W
    Neoplasia; 2009 Jan; 11(1):39-47. PubMed ID: 19107230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miRNA-34 prevents cancer initiation and progression in a therapeutically resistant K-ras and p53-induced mouse model of lung adenocarcinoma.
    Kasinski AL; Slack FJ
    Cancer Res; 2012 Nov; 72(21):5576-87. PubMed ID: 22964582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor activity of erlotinib (OSI-774, Tarceva) alone or in combination in human non-small cell lung cancer tumor xenograft models.
    Higgins B; Kolinsky K; Smith M; Beck G; Rashed M; Adames V; Linn M; Wheeldon E; Gand L; Birnboeck H; Hoffmann G
    Anticancer Drugs; 2004 Jun; 15(5):503-12. PubMed ID: 15166626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computed tomography imaging of primary lung cancer in mice using a liposomal-iodinated contrast agent.
    Badea CT; Athreya KK; Espinosa G; Clark D; Ghafoori AP; Li Y; Kirsch DG; Johnson GA; Annapragada A; Ghaghada KB
    PLoS One; 2012; 7(4):e34496. PubMed ID: 22485175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging primary lung cancers in mice to study radiation biology.
    Kirsch DG; Grimm J; Guimaraes AR; Wojtkiewicz GR; Perez BA; Santiago PM; Anthony NK; Forbes T; Doppke K; Weissleder R; Jacks T
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):973-7. PubMed ID: 20206017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing Therapeutic Efficacy of MEK Inhibition in a KRAS
    Li S; Liu S; Deng J; Akbay EA; Hai J; Ambrogio C; Zhang L; Zhou F; Jenkins RW; Adeegbe DO; Gao P; Wang X; Paweletz CP; Herter-Sprie GS; Chen T; Gutiérrez-Quiceno L; Zhang Y; Merlino AA; Quinn MM; Zeng Y; Yu X; Liu Y; Fan L; Aguirre AJ; Barbie DA; Yi X; Wong KK
    Clin Cancer Res; 2018 Oct; 24(19):4854-4864. PubMed ID: 29945997
    [No Abstract]   [Full Text] [Related]  

  • 8. Establishment of patient-derived non-small cell lung cancer xenografts as models for the identification of predictive biomarkers.
    Fichtner I; Rolff J; Soong R; Hoffmann J; Hammer S; Sommer A; Becker M; Merk J
    Clin Cancer Res; 2008 Oct; 14(20):6456-68. PubMed ID: 18927285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring of tumour progression using bioluminescence imaging and computed tomography scanning in a nude mouse orthotopic model of human small cell lung cancer.
    Iochmann S; Lerondel S; Bléchet C; Lavergne M; Pesnel S; Sobilo J; Heuzé-Vourc'h N; Le Pape A; Reverdiau P
    Lung Cancer; 2012 Jul; 77(1):70-6. PubMed ID: 22321610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effect of ginsenoside Rg3 combined with gemcitabine on angiogenesis and growth of lung cancer in mice.
    Liu TG; Huang Y; Cui DD; Huang XB; Mao SH; Ji LL; Song HB; Yi C
    BMC Cancer; 2009 Jul; 9():250. PubMed ID: 19624862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early detection of pre-malignant lesions in a KRAS
    Rakhit CP; Trigg RM; Le Quesne J; Kelly M; Shaw JA; Pritchard C; Martins LM
    Dis Model Mech; 2019 Feb; 12(2):. PubMed ID: 30760495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of angiogenesis using micro-computed tomography in a xenograft mouse model of lung cancer.
    Savai R; Langheinrich AC; Schermuly RT; Pullamsetti SS; Dumitrascu R; Traupe H; Rau WS; Seeger W; Grimminger F; Banat GA
    Neoplasia; 2009 Jan; 11(1):48-56. PubMed ID: 19107231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Model for mediastinal lymph node metastasis produced by orthotopic intrapulmonary implantation of lung cancer cells in mice.
    Yamaura T; Doki Y; Murakami K; Saiki I
    Hum Cell; 1999 Dec; 12(4):197-204. PubMed ID: 10834106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of KS-58 as the first K-Ras(G12D)-inhibitory peptide presenting anti-cancer activity in vivo.
    Sakamoto K; Masutani T; Hirokawa T
    Sci Rep; 2020 Dec; 10(1):21671. PubMed ID: 33303890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical analyses of intravesical chemotherapy for prevention of bladder cancer progression.
    Delto JC; Kobayashi T; Benson M; McKiernan J; Abate-Shen C
    Oncotarget; 2013 Feb; 4(2):269-76. PubMed ID: 23563166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin E δ-tocotrienol prolongs survival in the LSL-KrasG12D/+;LSL-Trp53R172H/+;Pdx-1-Cre (KPC) transgenic mouse model of pancreatic cancer.
    Husain K; Centeno BA; Chen DT; Hingorani SR; Sebti SM; Malafa MP
    Cancer Prev Res (Phila); 2013 Oct; 6(10):1074-83. PubMed ID: 23963802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Versatile and enhanced tumour modelling in mice via somatic cell transduction.
    Rodriguez E; Mannion L; D'Santos P; Griffiths M; Arends MJ; Brindle KM; Lyons SK
    J Pathol; 2014 Mar; 232(4):449-57. PubMed ID: 24307564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity of macrophage infiltration and therapeutic response in lung carcinoma revealed by 3D organ imaging.
    Cuccarese MF; Dubach JM; Pfirschke C; Engblom C; Garris C; Miller MA; Pittet MJ; Weissleder R
    Nat Commun; 2017 Feb; 8():14293. PubMed ID: 28176769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical therapeutic response of residual metastatic disease is distinct from its primary tumor of origin.
    Day CP; Carter J; Bonomi C; Hollingshead M; Merlino G
    Int J Cancer; 2012 Jan; 130(1):190-9. PubMed ID: 21312195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MUC16 Regulates TSPYL5 for Lung Cancer Cell Growth and Chemoresistance by Suppressing p53.
    Lakshmanan I; Salfity S; Seshacharyulu P; Rachagani S; Thomas A; Das S; Majhi PD; Nimmakayala RK; Vengoji R; Lele SM; Ponnusamy MP; Batra SK; Ganti AK
    Clin Cancer Res; 2017 Jul; 23(14):3906-3917. PubMed ID: 28196872
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.